Endotoxin, endotoxin-neutralizing-capacity, sCD14, sICAM-1, and cytokines in patients with various degrees of alcoholic liver disease

Alcoholism: Clinical and Experimental Research

Volumn 25, Issue 2, 2001, Pages 261-268

  Urbaschek, Renate ^a,d   McCuskey, Robert S ^b   Rudi, Volker ^c   Becker, Klaus Peter ^a   Stickel, Felix ^c   Urbaschek, Bernhard ^a   Seitz, Helmut K ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c Krankenhaus Salem   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cytokines; IL 10; LPS Inactivation; sCD14; sICAM

Indexed keywords

CD14 ANTIGEN; CYTOKINE; ENDOTOXIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOKINE PRODUCTION; ENDOTOXEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LIMULUS LYSATE TEST; LIVER INJURY; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL;

LIMULUS;

EID: 0035112937     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2001.tb02207.x     Document Type: Article

References (54)

1. Antibiotics prevent liver injury in rats following long-term exposure to ethanol
2. Leukocyte adhesion molecules and alcoholic liver disease
3. Inhibition of macrophages with gadolinium chloride alters intercellular adhesion molecule-1 expression in the liver during acute endotoxemia in rats
4. Effects of cytokines on liver
5. Chronic alcohol intoxication induces hepatic injury through enhanced macrophage inflammatory protein-2 production and intercellular adhesion molecule-1 expression in the liver
6. Biochemical characterization of a soluble form of the 53-kda monocyte surface antigen
7. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess
8. Tumor necrosis factor-alpha and interleukin-6 in plasma levels in infected cirrhotic patients
9. Effect of chronic alcohol consumption by rats on tumor necrosis factor-alpha and interleukin-6 clearance in vivo and by the isolated, perfused liver
10. Immune mechanism in alcoholic liver disease
11. Alcoholic liver disease
12. Quantitativer endotoxinnachweis. Automatischer, kinetischer limulus-amöbozyten-lysat-mikrotitertest mit messung probenabhängiger interferenzen
13. Serum intercellular adhesion molecule-1 in alcoholic liver disease and its relationship with histological disease severity
14. Alcohol causes both tolerance and sensitization of rat Kupffer cells via mechanisms dependent on endotoxin
15. Estriol sensitizes rat Kupffer cells via gut-derived endotoxin
16. Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis
17. Interaction of Kupffer cells to splenic macrophages and hepatocytes in endotoxin clearance: Effect of alcohol
18. Endotoxin inactivating action of plasma in patients with liver cirrhosis
19. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia
20. Interleukin-10 and the monocyte/macrophage-induced inflammatory response in septic shock
21. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage
22. Hyperhyaluronanemia in alcoholic hepatitis is associated with increased levels of circulating soluble intercellular adhesion molecule-1
23. Estrogen increases sensitivity of hepatic Kupffer cells to endotoxin
24. Release of soluble intercellular adhesion molecule 1 into bile and serum in murine endotoxin shock
25. Localisation on intrahepatic interleukin-6 in patients with acute and chronic liver disease
26. Role of defective monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholics cirrhosis
27. Endotoxin levels measured by chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis
28. Human monocyte IL-10 production is increased by acute ethanol treatment
29. Cytokines and alcoholic liver disease
30. Tumor necrosis factor and alcoholic liver disease
31. Effects of ethanol and cocaine alone or in combination on hepatic sinusoids of mice and rats
32. Endothelial-leukocyte adhesive interactions in inflammatory diseases
33. Role of eicosanoids in experimental alcoholic liver disease
34. Intercellular adhesion molecule-1 expression in experimental alcoholic liver disease: Relationship to endotoxemia and TNF alpha messenger RNA
35. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality
36. Ethanol exacerbates hepatic microvascular dysfunction, endotoxemia, and lethality in septic mice
37. Protective role of nitric oxide in hepatic microcirculatory dysfunction during endotoxemia
38. Prognostic significance of cholestatic alcoholic hepatitis
39. The role of endotoxin in liver injury
40. Increased in vitro production and serum levels of the soluble lipopolysaccharide receptor sCD14 in liver disease
41. Immunohistochemical detection of tumor necrosis factor-alpha, other cytokines and adhesion molecules in human livers with alcoholic hepatitis
42. Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia
43. Endotoxinämie und multiorganversagen nach polytrauma
44. Decreased endotoxin-binding capacity of whole blood in patients with alcoholic liver disease
45. Immunological parameters of alcoholics suffering from infection or sepsis in the internal ICU
46. Endotoxinneutralizing capacity of soluble CD14
47. Alcohol, cytokines and immunodeficiency
48. CD14 and lipopolysaccharide binding protein expression in a rat model of alcoholic liver disease
49. Regulation of human monocyte functions by acute ethanol treatment: Decreased tumor necrosis factor-α, interleukin-1β and elevated interleukin-10, and transforming growth factor-β production
50. Detection of endotoxin in plasma and ascitic fluid of patients with cirrhosis: Its clinical significance
51. Serum levels of cytokines in chronic liver disease
52. Quantification of endotoxin and sample-related interferences by using a kinetic Limulus amebocyte lysate microtiter test
53. Endotoxinnachweis im plasma. Spezifität und aussagekraft für entwicklung und prognose einer sepsis
54. sCD14, sICAM-1, cytokines, endotoxin and endotoxin-neutralizing-capacity during alcoholic liver disease